- €908.18m
- €685.40m
- €525.69m
Brief: FDA Conditionally Approves First Torsemide Animal Drug For Dogs
Brief: Vetoquinol FY EBIT at EUR 71.6 Million
Brief: Vetoquinol FY Annual Sales At EUR 529 Million
Live Markets: The mighty dollar's comeback
Live Markets: Searching for hidden gems? Stop here
France's Vetoquinol drops on profit taking
Brief: Vetoquinol Posts FY Sales OF EUR 529 Million
Brief: Vetoquinol Q3 Sales Up At 136 Million Euros
Brief: Euronext Announces Results Of Annual Review For CAC Family Indices
Brief: Vetoquinol H1 Net Income Group Share Amounts To EUR 32 Mln
Brief: Matthieu Frechin Appointed Chairman At Vetoquinol
Brief: Vetoquinol Q1 Sales Up At EUR 145 Mln
Brief: Vetoquinol FY EBITDA Amounts To EUR 118 Mln
French and Benelux stocks-Factors to watch
Brief: Vetoquinol FY Group Sales At EUR 540 Mln, Up 3.6% As Reported
French and Benelux stocks-Factors to watch
Brief: Vetoquinol 9-Month Revenue Up At EUR 405 Mln
Brief: Vetoquinol Updates "Ambition 2026" Strategy
Virbac halves 2022 debt reduction target, shares fall to bottom of SBF 120